Alzheimer’s disease associated with agitation
Do you have a loved one with agitation associated with Alzheimer's dementia?
Is their agitation becoming overwhelming?
Is someone you care for with Alzheimer's dementia exhibiting excessive motor activity, verbal and/or physical aggression?
If so, they may qualify for the ASPECT clinical research study. The purpose of this study is to evaluate the safety and the effectiveness of an investigational drug for agitation associated with Alzheimer's dementia.
To be eligible for this study, a potential participant must:
- Be between the ages of 50 and 90
- Have a diagnosis of probable Alzheimer's dementia
- Have moderate to severe agitation that interferes with their daily life
- Have a reliable caregiver who spends a minimum of 2 hours per day, 4 days per week with them and is willing and able to comply with all study procedures
Those who qualify will receive study-required medical care and study drug at no cost.
Apply now to learn more!
I want to apply to this clinical study
The study process in pictures
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Step 5 | If you are eligible, you may then begin a clinical study with us.